Pure Global

Drug-coated stent for the treatment of coronary artery disease - Vietnam Registration 2402667ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Drug-coated stent for the treatment of coronary artery disease in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402667ĐKLH/BYT-HTTB and manufactured by Hemoteq AG. The authorized representative in Vietnam is CÔNG TY TNHH BOSTON SCIENTIFIC VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo theo phụ lục, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
2402667ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402667ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug-coated stent for the treatment of coronary artery disease
VN: Bóng nong mạch vành phủ thuốc Paclitaxel
Risk Class TTBYT Loại D

Registration Details

2402667ĐKLH/BYT-HTTB

000.00.04.G18-221011-0016

Agent™ MONORAIL Paclitaxel-Coated PTCA Balloon Catheter

Theo phụ lục

Company Information

Theo theo phụ lục

Hemoteq AG

Technical Details

The Paclitaxel-Eluting Vascular Bonding Agent is indicated for the treatment of in-stent restenosis (ISR) and de novo / small vessel disease in PTCA (percutaneous transluminal coronary angioplasty).

Dates and Status

Oct 02, 2024

Companies Making Similar Products
Companies providing products similar to "Drug-coated stent for the treatment of coronary artery disease"